AdvaMed, Medtech Leaders From Across the Country Meet with Lawmakers This Week
Senate committee passage of Medical Device User Fee Amendments legislation is an important step toward improving FDA review of medical technology to help patients.
AdvaMed Welcomes Senate Committee Passage of MDUFA V Legislation
Senate committee passage of Medical Device User Fee Amendments legislation is an important step toward improving FDA review of medical technology to help patients.
AdvaMed Welcomes Progress for Medtech Patients at Summit of the Americas
The Advanced Medical Technology Association, AdvaMed, today welcomed several outcomes of the just-concluded IX Summit of the Americas in Los Angeles.
AdvaMed Commends Full House Passage of MDUFA V Agreement
The Advanced Medical Technology Association (AdvaMed) welcomes House passage of the MDUFA V agreement.
In New Report, AdvaMed Seeks Ways to Increase Diversity in Clinical Research and Addressing Health Equities
The Advanced Medical Technology Association (AdvaMed) released a report titled “Approaches to Increasing Diversity in Clinical Research and Addressing Health Inequities”, a new document intended to outline considerations and approaches…
AdvaMed, Member Company Executives Meet with Semiconductor Industry, Department of Commerce Officials on Chips to Ensure Patient Care Comes First
Scott Whitaker, President and CEO of the Advanced Medical Technology Association (AdvaMed), the largest global trade organization representing the medical technology sector, joined a meeting with Deputy Secretary of Commerce…
AdvaMed Joins Biden Administration Working Group to Address Medtech Supply Chain Concerns That Could Soon Affect Patient Care
The Advanced Medical Technology Association (AdvaMed), the world’s largest trade organization representing medical technology manufacturers, announced its new role in the Biden Administration’s Joint Supply Chain Resilience Working Group.
AdvaMed Commends Unanimous House Committee Vote on MDUFA V Agreement
Scott Whitaker, president and CEO of AdvaMed, the world’s largest trade association representing medical technology companies, released the following statement on progress this week in both houses of Congress.
New for Upcoming MedTech Conference: AdvaMed Announces Investor Forum, Including Session with Chief Executives for Corporate Purpose
Following the release of the House Energy and Commerce Committee’s FDA User Fees Legislative Package, the Advanced Medical Technology Association (AdvaMed) released this statement from President and CEO Scott Whitaker.
AdvaMed Welcomes FDA User Fee Legislative Package
Following the release of the House Energy and Commerce Committee’s FDA User Fees Legislative Package, the Advanced Medical Technology Association (AdvaMed) released this statement from President and CEO Scott Whitaker.